The treatment option can have a positive impact on quality of life for patients.
Allen C. Ho, MD, FACS, FASRS
Advertisement
Articles by Allen C. Ho, MD, FACS, FASRS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Phase 3 NORTHSTAR trial launches for gildeuretinol in stargardt disease
2
TECNIS PureSee IOL launches in US following FDA approval for cataract surgery
3
Dompé initiates phase 3 Orunea trial of cenegermin-bkbj in PCED
4
Everest medicines acquires greater china rights to aceclidine presbyopia eye drop (VIZZ)
5